FTI CONSULTING, INC (FCN) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
61/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseFCN / S&P -15.70% / 15.20% |
LoseFCN / S&P 7.12% / 15.00% |
LoseFCN / S&P 16.90% / 50.40% |
| 2026-Q11/3 |
WinFCN / S&P 3.48% / -4.33% |
LoseFCN / S&P 5.60% / 11.30% |
LoseFCN / S&P 15.46% / 27.70% |
| 2025-Q41/3 |
WinFCN / S&P 5.68% / 2.65% |
LoseFCN / S&P 2.44% / 9.00% |
LoseFCN / S&P 6.15% / 13.40% |
| 2025-Q30/3 |
LoseFCN / S&P 0.09% / 8.12% |
LoseFCN / S&P -0.95% / 4.61% |
LoseFCN / S&P -9.77% / 13.45% |
| 2025-Q20/3 |
LoseFCN / S&P -1.57% / 10.94% |
LoseFCN / S&P -0.89% / 4.83% |
LoseFCN / S&P -22.74% / 10.63% |
| 2025-Q10/3 |
LoseFCN / S&P -14.15% / -4.27% |
LoseFCN / S&P 1.59% / 4.98% |
LoseFCN / S&P -15.00% / 10.57% |
| 2024-Q41/3 |
LoseFCN / S&P -16.01% / 2.41% |
WinFCN / S&P 6.00% / 5.25% |
LoseFCN / S&P 1.17% / 6.15% |
| 2024-Q32/3 |
LoseFCN / S&P 5.58% / 5.89% |
WinFCN / S&P 11.66% / 5.89% |
WinFCN / S&P 28.70% / 6.11% |
| 2024-Q22/3 |
LoseFCN / S&P 2.49% / 4.28% |
WinFCN / S&P 14.72% / 5.38% |
WinFCN / S&P 39.88% / 5.12% |
| 2024-Q12/3 |
LoseFCN / S&P 5.59% / 10.56% |
WinFCN / S&P 16.04% / 5.71% |
WinFCN / S&P 37.60% / 5.59% |
| 2023-Q42/3 |
LoseFCN / S&P 11.62% / 11.69% |
WinFCN / S&P 15.20% / 6.81% |
WinFCN / S&P 17.35% / 7.78% |
| 2023-Q32/3 |
LoseFCN / S&P -6.20% / -3.27% |
WinFCN / S&P 13.93% / 7.52% |
WinFCN / S&P 7.13% / -5.03% |
| 2023-Q22/3 |
LoseFCN / S&P -3.62% / 8.74% |
WinFCN / S&P 12.76% / 9.50% |
WinFCN / S&P 7.35% / -8.57% |
| 2023-Q12/3 |
WinFCN / S&P 24.28% / 7.50% |
LoseFCN / S&P 10.61% / 10.77% |
WinFCN / S&P -3.25% / -15.69% |
| 2022-Q41/3 |
LoseFCN / S&P -4.17% / 7.56% |
LoseFCN / S&P 9.10% / 11.88% |
WinFCN / S&P -1.05% / -17.99% |
| 2022-Q30/3 |
LoseFCN / S&P -8.37% / -4.88% |
LoseFCN / S&P 7.49% / 13.47% |
LoseFCN / S&P -11.50% / -1.41% |
| 2022-Q21/3 |
WinFCN / S&P 15.03% / -16.10% |
LoseFCN / S&P 7.95% / 13.71% |
LoseFCN / S&P -6.13% / 11.04% |
| 2022-Q11/3 |
WinFCN / S&P 2.48% / -4.60% |
LoseFCN / S&P 10.64% / 15.97% |
LoseFCN / S&P 7.31% / 42.23% |
| 2021-Q41/3 |
WinFCN / S&P 13.90% / 11.03% |
LoseFCN / S&P 12.80% / 15.00% |
LoseFCN / S&P 17.11% / 96.40% |
| 2021-Q31/3 |
LoseFCN / S&P -1.40% / 0.58% |
WinFCN / S&P 11.89% / 10.77% |
LoseFCN / S&P 46.11% / 69.42% |
| 2021-Q21/3 |
LoseFCN / S&P -2.50% / 8.55% |
WinFCN / S&P 9.92% / 6.58% |
LoseFCN / S&P 27.34% / 51.81% |
| 2021-Q13/3 |
WinFCN / S&P 25.41% / 6.17% |
WinFCN / S&P 5.69% / -1.06% |
WinFCN / S&P 8.66% / 7.39% |
| 2020-Q42/3 |
LoseFCN / S&P 5.43% / 12.15% |
WinFCN / S&P 4.61% / -3.72% |
WinFCN / S&P -0.35% / -33.42% |
| 2020-Q32/3 |
LoseFCN / S&P -7.49% / 8.93% |
WinFCN / S&P 8.04% / -2.04% |
WinFCN / S&P -11.75% / -27.10% |
| 2020-Q22/3 |
LoseFCN / S&P -4.36% / 20.54% |
WinFCN / S&P 10.68% / -0.46% |
WinFCN / S&P 0.79% / -27.11% |
| 2020-Q13/3 |
WinFCN / S&P 8.23% / -19.60% |
WinFCN / S&P 15.60% / 3.47% |
WinFCN / S&P 22.30% / -14.75% |
| 2019-Q42/3 |
LoseFCN / S&P 4.41% / 9.07% |
WinFCN / S&P 16.02% / 5.36% |
WinFCN / S&P 44.78% / 2.99% |
| 2019-Q33/3 |
WinFCN / S&P 26.42% / 1.70% |
WinFCN / S&P 13.31% / 5.02% |
WinFCN / S&P 9.72% / 0.21% |
| 2019-Q22/3 |
WinFCN / S&P 9.14% / 4.30% |
WinFCN / S&P 12.92% / 6.64% |
LoseFCN / S&P 6.95% / 8.65% |
| 2019-Q13/3 |
WinFCN / S&P 15.28% / 13.65% |
WinFCN / S&P 11.95% / 8.12% |
WinFCN / S&P 30.17% / 14.29% |
| 2018-Q43/3 |
WinFCN / S&P -8.95% / -13.52% |
WinFCN / S&P 12.18% / 9.05% |
WinFCN / S&P 41.37% / 18.23% |
| 2018-Q33/3 |
WinFCN / S&P 21.02% / 7.71% |
WinFCN / S&P 11.71% / 10.21% |
WinFCN / S&P 309.76% / 19.06% |
| 2018-Q22/3 |
WinFCN / S&P 24.93% / 3.43% |
LoseFCN / S&P 8.78% / 9.03% |
WinFCN / S&P 427.78% / 14.46% |
| 2018-Q12/3 |
WinFCN / S&P 12.69% / -0.76% |
LoseFCN / S&P 4.07% / 7.68% |
WinFCN / S&P 108.38% / 12.46% |
| 2017-Q42/3 |
WinFCN / S&P 21.08% / 6.64% |
LoseFCN / S&P -0.15% / 7.03% |
WinFCN / S&P 34.95% / 13.82% |
| 2017-Q30/3 |
LoseFCN / S&P 1.49% / 4.48% |
LoseFCN / S&P -1.59% / 5.68% |
LoseFCN / S&P -42.25% / 17.57% |
| 2017-Q20/3 |
LoseFCN / S&P -15.08% / 3.09% |
LoseFCN / S&P -3.12% / 4.83% |
LoseFCN / S&P -51.61% / 17.74% |
| 2017-Q10/3 |
LoseFCN / S&P -8.67% / 6.07% |
LoseFCN / S&P -1.69% / 3.67% |
LoseFCN / S&P -4.02% / 13.32% |
| 2016-Q41/3 |
LoseFCN / S&P 1.17% / 3.82% |
LoseFCN / S&P 1.76% / 2.09% |
WinFCN / S&P 30.38% / 7.05% |
| 2016-Q33/3 |
WinFCN / S&P 9.54% / 3.85% |
WinFCN / S&P 2.76% / 0.20% |
WinFCN / S&P 57.78% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | FCN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -9.87% | 20.78% |
| Annualized return | -9.87% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | FCN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 8.11% | 83.14% |
| Annualized return | 1.57% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | FCN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 241.55% | 319.30% |
| Annualized return | 13.07% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| Genpact LTD (G) | $5.608B | 7.94 | |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |
| TSS, Inc. (TSSI) | United States | $0.288B | 24.06 |